Objective To develop a set of core outcomes to be minimally reported in trials on induction of labour.
Introduction
Induction of labour is one of the the most common procedures undertaken in obstetrics; one in every five deliveries in the United Kingdom (UK) is induced. 1 Numerous randomised trials have reported various outcomes when evaluating the effects of interventions for induction of labour. 2 Variations in reported outcomes hamper translation of evidence into clinical practice, resulting in research waste. [3] [4] [5] There are no systematic reviews on outcomes reported in trials of induction of labour but it is recognised that there is a need to develop a core outcome set (COS) for trials on induction of labour to improve the quality of evidence synthesis. 2 Careful selection of primary and secondary outcomes is a key component of clinical trial design 6 but very few trials provide the rationale for outcome selection. 2 Many trials on induction of labour include surrogate continuous markers such as time to delivery, but provide limited or no information on maternal and offspring mortality and morbidity. 2 Maternal satisfaction, safety data, and measures of cost are also poorly reported. 2 Any reported outcomes should be relevant to key stakeholders if they are to be used to influence clinical decisions and further research. 7 The current drive to standardise outcome reporting in clinical trials led by COMET (Core Outcome Measures in Effectiveness Trials) has been taken up by various specialties. 8 The CROWN (Core Outcomes in Women's Health) initiative encourages the development of core outcome sets, which are the minimum outcomes to be reported in clinical trials in women's and newborn health. [8] [9] [10] Given the variation in outcome reporting, we developed a set of core outcomes for reporting in trials of induction of labour using the Delphi technique.
The scope of this work is to identify a set of minimal outcomes to be reported in clinical trials on induction of labour, for any indication, in singleton pregnancies at term.
Methods
The study was conducted in line with COMET recommendations 6, 11 with a prospective protocol and was registered with the CROWN and COMET databases 8 (Registration Number: 695, available online at www.comet-initiative.org/studies/details/695). We followed the COS-STAR statement checklist for reporting. 12 An 11-member international Project Steering Committee (PSC) consisting of five obstetricians, two neonatologists, two midwives, one researcher, and one women's representative provided input through the different stages of the project.
Literature search and identification of relevant outcomes
We undertook an electronic search of the Cochrane Database of Systematic Reviews with the search term 'induction of labour' for studies published up to 31 May 2015. The outcomes were combined and arranged into seven domains by the PSC: short-term for the women, short-term for the infant, long-term for the women, long-term for the child, maternal satisfaction, effectiveness, and cost. The studies identified and included from our search can be found in Table S1 .
Identification of stakeholders
We included four stakeholder groups: obstetricians, neonatologists, midwives, and women's representatives. Obstetricians and neonatologists were invited through mailing lists of the National Health Service (NHS) Trusts and Journal editors, members of the Global Obstetric Network (GONet), medical societies such as the British Association of Perinatal Medicine, Perinatal Society of Australia and New Zealand, specialist groups such as London Labour Ward Leads forum, and through referred contacts. Midwives were invited through mailing lists of NHS Trusts, through email discussion groups, and through a mailing list of an ongoing UK-wide intrapartum clinical trial. 13 We invited women's representatives from the Royal College of Obstetricians and Gynaecologists (RCOG) Women's Voices Involvement Panel mailing list, 14 Katie's Team 15 (a patient and public advisory group), and social media (private maternity group on Facebook and an invitation poster posted on Twitter-Appendix S1). Women's representatives had to have had experienced induction of labour themselves or supported a relative/friend undergoing induction of labour. Our aim was to recruit at least 25 participants in each of the stakeholder groups.
Delphi survey
We undertook a two-round confidential e-Delphi survey. Each round closed after 4 weeks. A reminder was sent to all participants who had not completed the survey on days 7, 14, and 21. Nonresponders to the first round were not invited to the subsequent round.
Round one
We sent a link to the Web-based questionnaire (Appendix S2) to stakeholders using Survey Monkey â (Survey Monkey Inc, San Mateo, CA, USA). Participants were asked to score a long list of potential outcomes for importance in including in a core outcome set, using a 9-point Grading of Recommendations Assessment, Development and Evaluation (GRADE) scale: 16 scores 1 to 3-limited importance; 4 to 6-important but not critical; 7 to 9-critical. We provided all stakeholders with a document that explained in lay terms the meaning of each outcome (Appendix S3), which was informed by the Plain Language Medical Dictionary.
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Participants were invited to suggest additional relevant outcomes (no limit to the number of outcomes suggested) using free-text responses. The PSC reviewed these outcomes for addition to the next round of the survey. We determined a priori the criteria for consensus. 'Consensus in' (outcome to be included in the COS) required 70% or more of participants to score the outcome as being critical and <15% of participants to score the outcome as being of limited importance. 'Consensus out' (outcome not to be included in the core outcome set) required 70% or more of participants to score the outcome as being of limited importance and <15% of participants to score the outcome as being critical. Outcomes that did not meet any of these criteria were labelled as 'no consensus'. 18 The median scores of each outcome were calculated as a whole and for each individual stakeholder group.
Round two
Outcomes that reached 'consensus in' or 'consensus out' in round one were not taken forward to round two. Outcomes suggested by stakeholders in the first round of the survey were evaluated by the PSC and used in round two as separate items. Outcomes with 'no consensus' status and the additional outcomes suggested by participants were included for rating by participants in round two. We provided the median scores for each outcome by stakeholder group in round one and the participants' own score. They were requested to reflect on their previous rating and rating by stakeholder group before rescoring the outcomes for a second time using the same scale (Appendix S4).
Consensus meeting
We invited all the participants who had completed both rounds of the survey to attend a consensus meeting in Amsterdam in 2017. Those who could not attend the meeting were invited to participate via teleconference. We additionally requested intrapartum care experts to join the meeting. The consensus group voted on the 'no consensus' outcomes from the Delphi rounds, and evaluated the final list of 'consensus in' outcomes and made suggestions on combining outcomes where there was significant overlap between components. 19 Stakeholder groups who were unable to be represented in the consensus meeting were sent the final list of outcomes for comments. The PSC took these comments into consideration before finalising the COS.
The Delphi questionnaire scores were analysed using Microsoft â EXCEL for MAC, version 15.33, 2017 (Microsoft Corp., Redmond, WA, USA).
Results
We identified 32 (Table S1 ) reviews from the literature search, extracted all the different outcomes reported (n = 155), and created a comprehensive list of potential core outcomes. By combining similar outcomes, the number of outcomes was reduced to 93 by the PSC. The stakeholders who agreed to participate in the Delphi process were from the UK, Australia, China, Ireland, the Netherlands, and Portugal. The first round of the Delphi survey was sent to 159 participants (44 obstetricians, 30 neonatologists, 54 midwives, and 31 women's representatives). About half of all participants (54%, 86/159) completed the first round (26 obstetricians, 15 neonatologists, 27 midwives, and 18 women's representatives). The second round was completed by 71 participants (83%, 71/86-24 obstetricians, 9 neonatologists, 21 midwives, and 17 women's representatives).
An initial list of 93 outcomes ( Figure 1 ) was reduced to 77 by combining similar components (Table 1) , following suggestions from the stakeholders participating in round one and prior to calculating the median scores for each outcome. At the end of round one, 18 of the 77 outcomes were 'consensus in', none was 'consensus out', and 59 were 'no consensus' (Table S2) . Stakeholders suggested the addition of 'umbilical cord pH', 'need for therapeutic hypothermia', 'amniotic fluid embolism', and 'intrapartum stillbirth' to the survey.
Of the 63 outcomes rated in round two, 14 were categorised as 'consensus in', none was 'consensus out', and 49 were 'no consensus' (Table S3) .
The final consensus meeting included eight obstetricians, one midwife, and three researchers. Further input was obtained via email from two obstetricians, three women's representatives and three neonatologists ( Table 2) . Of the 49 'no consensus' outcomes, four were voted to be included in the final core outcome set: 'uterine hyperstimulation', 'more than one induction agent required', 'length of hospital stay', and 'oxytocin augmentation'. Due to the high number of 'consensus in' outcomes (n = 36), the participants of the consensus meeting combined 14 of these into six new outcomes ( Table 3) .
The final set included 28 core outcomes in four domains (Table 4) : short-term maternal outcomes (n = 18), shortterm offspring outcomes (n = 8), long-term maternal outcomes (n = 1), and long-term offspring outcomes (n = 1).
Discussion

Main findings
An international multistakeholder group including women's representatives identified 28 maternal and offspring outcomes as minimally reported in trials of induction of labour. Researchers may have their own hypotheses/ outcomes to explore, and these should be added to this COS.
Strengths and limitations
Our main strength was the use of published guidelines to develop and report this COS. 6, 12 The women's representatives group was strongly represented and had the lowest attrition rate. Patient involvement is essential to identify outcomes most relevant to patients/carers. [20] [21] [22] Currently, trials on induction of labour mainly concentrate on outcomes relevant to healthcare professionals. Patients might regard 'anxiety during induction of labour' and how their relationship with their partner is affected as more important. [23] [24] [25] By involving obstetricians, midwives, and neonatologists from different countries, we captured different perspectives. We created a plain language summary mainly targeting the women's representatives group. Health professionals also seem to prefer plain English terms over technical terms; 22 hence, we sent this document to all participants. We used the Delphi technique to achieve consensus, which has been used in the development of several COS. 11 It allows confidentiality, wide geographical distribution, and avoids the potential overinfluence of dominant individuals. 22, 26 By limiting our search to a single database and by not performing a systematic review, we might have missed Outcomes combined and arranged into 4 domains: short-term maternal outcomes (n = 18), short-term offspring outcomes (n = 8), long-term maternal outcomes (n = 1) and long-term offspring outcomes (n = 1) - Table 4 Final Core Outcome Set, N = 28 14 "consensus in" outcomes combined into 6 new outcomes (consensus meeting - Table  3 ) reducing the final number from 36 to 28 core outcomes. outcomes reported, which is a limitation. Induction of labour is a common procedure and we identified a significant number of reported outcomes. Large systematic reviews are time-consuming and may not provide additional outcomes for common conditions. 22 Outcomes were presented in alphabetical order, which may have influenced the responses/response rate, 27 but we are not aware of a different strategy. We chose to do two rounds of the Delphi survey due to time constraints, but usually three iterations are sufficient to achieve consensus, 22 which we did with the final consensus meeting. The attrition rate was high for the first round of the survey but lower for the second round, which is not uncommon in multiround surveys. 28 The attrition rates were higher for the neonatologists' group, and we addressed this by sending individual emails to those initially invited and by extending the survey response deadline by 2 weeks for both rounds. Despite this being a protocol deviation, we did not want a particular stakeholder group to be underrepresented. Even with all these efforts, the neonatologists group remained the least represented stakeholder group which is one of our biggest limitations. This might have affected the final list of outcomes for the offspring. We invited all the participants in the Delphi survey to attend the consensus meeting. Another limitation was that the meeting was held abroad and the attendance rate was low. We allowed participation via teleconference and comments via email after the COS had been agreed at the meeting. Obstetricians, neonatologists, and women's representatives sent comments via email, and we took these into consideration prior to finalising the COS. Another limitation of our study is the potential knowledge gap incurred by not including stakeholders from large high-income countries such as the USA, and low-and middle-income countries. 29 Although we used global platforms and social media to invite stakeholders, certain countries remained underrepresented. One potential limitation of this study is the high number of outcomes in our final COS. Due to the nature of induction of labour interventions, we had to include outcomes for both women and offspring. There are currently Table 1 . Simplification of outcomes as suggested by the stakeholders after the first round of the Delphi survey used for the development of a core outcome set for trials on induction of labour (COSIOL). The second column represents the 'new combined outcome' which results from the combination of one or more outcomes
Outcomes combined
New combined outcome
Deep vein thrombosis + thrombophlebitis requiring anticoagulant therapy Deep vein thrombosis
Haemorrhage (blood loss >500 ml at vaginal birth or >1000 ml at caesarean birth + haemorrhage requiring blood transfusion
Haemorrhage (blood loss >500 ml at vaginal birth or >1000 ml at caesarean birth) four published core outcome sets in women's and newborn health, 19 with outcome numbers ranging from 11 to 48.
Interpretation
Short-and long-term maternal outcomes Our COS captured outcomes that are commonly reported, such as 'time from induction of labour to delivery' (reported in >50% of trials 2 ), but also outcomes which are less commonly reported, such as 'maternal satisfaction' (reported in 5% of trials 2 ) and 'maternal death' (reported in 12% of trials 2 ). We combined 'uterine scar dehiscence' with 'uterine scar rupture', as uterine scar dehiscence would not be recognised during labour and therefore would not not have changed management. It would, however, require repair, once identified. 'Chorioamnionitis', 'septicaemia', and 'puerperal infection' are a spectrum of maternal infections, hence the panellists' decision to combine them. 'Cardiac' and 'respiratory arrest' are rare events in maternity and often occur together, hence they were combined as one outcome. Regarding 'mode of delivery', researchers might want to differentiate between vaginal delivery, instrumental delivery, and caesarean section. Trials on induction of labour almost always report on caesarean section and about half report instrumental delivery rates. 2 The participants of the Delphi process and consensus meeting reached a consensus that this should be minimally reported. 'Uterine hyperstimulation' was included as panellists thought it may change an outpatient induction into an inpatient induction, Table 3 . Simplification of outcomes as suggested by the stakeholders at the consensus meeting for the development of a core outcome set for trials on induction of labour (COSIOL). The first column represents the outcomes which were combined into a 'new combined outcome'
Outcomes combined
Uterine scar dehiscence (defined as clinically asymptomatic disruption of the uterus that is discovered incidentally at surgery) + rupture (defined as clinically significant rupture involving the full thickness of the uterine wall and requiring surgical repair)
Uterine scar dehiscence (defined as clinically asymptomatic disruption of the uterus that is discovered incidentally at surgery) or rupture (defined as clinically significant rupture involving the full thickness of the uterine wall and requiring surgical repair) Puerperal infection + chorioamnionitis + septicaemia Maternal infection Cardiac arrest + respiratory arrest Cardiorespiratory arrest Long-term disability + neurodevelopmental delay Long-term disability including neurodevelopmental delay Neonatal death + death after discharge from the hospital + intrapartum stillbirth Death of the baby (intrapartum/neonatal/perinatal) Hypoxic ischaemic encephalopathy + need for therapeutic hypothermia Hypoxic ischaemic encephalopathy or need for therapeutic hypothermia could lead to earlier medical intervention, and increase hospital stay. Women's representatives made important suggestions on the potential consequences of induction of labour, such as reduced contraction efficiency and reduction in prelabour oxytocin and prolactin receptors with a subsequent impact on breastfeeding, maternal adaptation, and maternal-infant bond. 27 'Breastfeeding at discharge', 'impact on maternalnewborn bonding', and 'impact on maternal mood' were included in the initial list of outcomes but did not reach consensus. The underrepresentation of women's representatives at the consensus meeting might have contributed to these outcomes not being included.
At the consensus meeting, participants were satisfied with the only long-term maternal outcome included, as induction of labour increases the risk of operative vaginal delivery 1 and therefore the 'need for operative pelvic floor repair'. If funding is not available for long-term follow up, the researchers can justify not reporting the long-term outcomes, but efforts should be made to follow this avenue if future funding becomes possible.
Short-and long-term offspring outcomes
The participants of the consensus meeting were satisfied with all the offspring outcomes. 'Apgar score <7 at 5 minutes' is nearly always reported in trials of induction of labour. 2 Stakeholders suggested that this outcome might be useful in low-resource settings and should be included in that case. Only 21% of trials report on neonatal death and 36% report on NICU admission-we captured both. 'Hypoxic ischaemic injury' (HIE) was grouped with 'need for therapeutic hypothermia', as therapeutic hypothermia is a surrogate marker for HIE. 30 'Neonatal death', 'death after discharge from the hospital', and 'intrapartum stillbirth' were combined into 'death of the baby (intrapartum/ neonatal/perinatal)'.
The consensus meeting participants suggested combining 'long-term disability' and 'neurodevelopmental delay' into 'long-term disability including neurodevelopmental delay'. If funding is not available for long-term follow up, the researchers can justify not reporting the long-term outcomes.
Measures of cost
Although none of the cost-orientated outcome measures is included in our COS, these should be considered in the case of a randomised trial comparing cost-effectiveness of different agents. Currently, only 10% of trials report costs. 2 
Conclusion
We encourage investigators undertaking future research on induction of labour to report on this COS of 28 outcomes as a minimum. By implementing and disseminating this COS in future research on induction of labour, we hope to minimise reporting bias by allowing evidence synthesis across different trials.
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It is beyond the scope of this study to provide definitions for each specific outcome or provide instruments for measurement. Guidelines on how to select outcome measurement instruments have been published. 31 Until these are developed, we suggest researchers describe how outcomes have been measured.
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